Glenmark licensing deal with Particle Sciences to develop and commercialise generic Abraxane
Glenmark Pharmaceuticals, Inc., USA (Glenmark) has entered into a strategic development, license and commercialization agreement with Particle Sciences, Inc. to develop and... Read More
Strides Arcolab to buy Aspen’s generics biz for Australian Dollar 380 million
Strides Pharma Global Pte. Ltd and Strides (Australia) Pharma Pty Ltd, Australia, both wholly-owned subsidiaries of Strides Arcolab have signed definitive agreement... Read More